Skip to Main Content

Paper Details

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
NPJ Breast Cancer
9
2021
Author NameAffiliation
Martin V BennetzenUniversity of Southern Denmark
Jens S AndersenUniversity of Southern Denmark
  • 1 - 2

Datasets

Release 1.2